hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06363188, orgStudyIdInfo id: effect of ESWT on fractures, briefTitle: The Impact of ESWT on Healing of Fractured Mandible, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2025-08-30, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: studying if using extracorporeal radial shockwave therapy as an adjuvant therapy help in accelerating the bone healing and regeneration in mandibular fractures by comparing it with the standard protocol for fractures fixation by plates and screws., conditionsModule conditions: Fractured Mandible Due to Trauma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: Radial Extracorporeal shockwave, outcomesModule primaryOutcomes measure: bone healing (denisty of bone), secondaryOutcomes measure: pain sensation, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Cairo Univeristy, status: RECRUITING, city: Cairo, country: Egypt, contacts name: khloud nasr eldin, GP, role: CONTACT, phone: 01014919174, email: khloud.ahmed@dentistry.cu.edu.eg, contacts name: Emad Saied, prof., role: CONTACT, phone: 01222117986, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06363162, orgStudyIdInfo id: LRR202404, briefTitle: Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-12-01, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Beijing Tiantan Hospital, class: OTHER, collaborators name: West China Hospital, collaborators name: The First Affiliated Hospital of Zhengzhou University, collaborators name: Capital Medical University, collaborators name: Jiangsu Raman Medical Equipment Co., Ltd., descriptionModule briefSummary: To distinguish various molecular subtypes of gliomas by spectra data obtained from Raman analyzer, including IDH mutant, 1p/19q-codeleted, ATRX deletion, TERT promoter mutation, MGMT promoter methylation, EGFR amplification, H3 K27-altered, TP53 mutant, PTEN deficiency, ki 67, AQP4, VEGF, and so on, comparing with the results of Immunohistochemistry or genetic test on the same brain tissue samples., conditionsModule conditions: Glioma, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: The same sample was diagnosed using Raman spectroscopy and immunohistochemistry or genetic test, respectively. Calculate the AUC, the accuracy, the sensitivity and specificity of a Raman analyzer using immunohistochemistry or genetic test results as the gold standard., primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, maskingDescription: Blind assessment: Researchers using Raman analyzer during surgery are not aware of the subjects' preoperative diagnostic results, while researchers conducting immunohistochemistry or genetic test after surgery are not aware of the subjects' preoperative diagnostic results and the diagnostic results of Raman analyzer., enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: Immunohistochemistry or genetic test, outcomesModule primaryOutcomes measure: Area Under the Curve, primaryOutcomes measure: Accuracy, secondaryOutcomes measure: Sensitivity, secondaryOutcomes measure: Specificity, secondaryOutcomes measure: Kappa coefficient, secondaryOutcomes measure: Time consumption for the Raman analyzer in detection, secondaryOutcomes measure: Adverse Event Incidence Rate, secondaryOutcomes measure: Serious Adverse Event Incidence Rate, secondaryOutcomes measure: Operator adverse events, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Beijing Tiantan Hospital, status: RECRUITING, city: Beijing, state: Beijing, zip: 100071, country: China, contacts name: Yinyan Wang, MD and PhD, role: CONTACT, phone: +86 13581698953, email: tiantanyinyan@126.com, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06363149, orgStudyIdInfo id: 2024-11-DM-136, briefTitle: Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-12, primaryCompletionDateStruct date: 2025-09, completionDateStruct date: 2025-09, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: Sanjay Gandhi Postgraduate Institute of Medical Sciences, class: OTHER_GOV, descriptionModule briefSummary: Septic shock is common complication in patients with critical illnesses, with higher incidence in low and medium income countries like ours. Disseminated intravascular coagulation (DIC) is also common in patients presenting to intensive care units. Further DIC is common coexisting condition seen in many patients presenting with sepsis and septic shock.Both DIC and septic shock individually are associated with very high mortality and morbidity and coexistence of both increase risk manifold. Organ dysfunction is a complication of both septic shock and DIC individually and in presence of coexistence risk further multiply. DIC scoring of every patient at risk as in patients presenting with septic shock help us to predict about patients having more chances to convert to overt DIC.Understanding effects of DIC on organ dysfunction in septic shock patients can help to prognosticate and guide towards early intervention. Also, there is paucity of literature on effect of DIC score changes on organ dysfunction in patients with septic shock., conditionsModule conditions: Septic Shock, conditions: Disseminated Intravascular Coagulation, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Effect of Disseminated Intravascular Coagulation score changes on organ dysfunction in septic shock patients at day 7, secondaryOutcomes measure: Effect of Disseminated Intravascular Coagulation score changes on organ dysfunction in septic shock patients at day 14, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Sanjay Gandhi Postgraduate Institute of Medical Sciences, status: RECRUITING, city: Lucknow, state: Uttar Pradesh, zip: 226014, country: India, contacts name: Mohan Gurjar, MD, PDCC, role: CONTACT, contacts name: Dinesh Chandra, MD, DM, role: CONTACT, contacts name: Mohan Gurjar, MD, PDCC, role: PRINCIPAL_INVESTIGATOR, contacts name: Sanjay Chaudhary, MD, role: SUB_INVESTIGATOR, contacts name: Dinesh Chandra, MD, DM, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 26.83928, lon: 80.92313, hasResults: False
protocolSection identificationModule nctId: NCT06363136, orgStudyIdInfo id: 14.06.2023-111176, briefTitle: Foot Posture, Strength, Performance, and Postural Control in Isolated Gastrocnemius Tightness, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-05-30, completionDateStruct date: 2024-06-30, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Bezmialem Vakif University, class: OTHER, descriptionModule briefSummary: Studies on gastrocnemius tightness in healthy children are limited, but there is evidence that ankle dorsiflexion decreases with increasing age in children. It is not known whether gastrocnemius tightness is a normal finding in children, but recurrent leg pain is common in children. It is also known that flexible flatfoot is a normal observation in developing children and that the medial longitudinal arch develops during the first decade of life. Both foot morphology and ankle dorsiflexion change in developing children; however, it is not known whether there is a relationship between them or not.In the literature, there is no study evaluating foot posture, muscle strength, functional performance, and postural control in children with isolated gastrocnemius muscle tightness. It was planned to evaluate postural control using computerized dynamic posturography (Biodex Balance System), lower extremity muscle strength using a hand-held dynamometer, foot posture using the Foot Posture Index (FPI-6), and functional performance using single-foot-double-foot jump tests in healthy children with isolated gastrocnemius muscle tightness., conditionsModule conditions: Gastrocnemius Tightness, conditions: Postural Control, conditions: Muscle Strength, conditions: Functional Performance, conditions: Foot Posture, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 28, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Postural Control Assessment, primaryOutcomes measure: Lower extremity muscle strength measurement, secondaryOutcomes measure: Foot posture assessment, secondaryOutcomes measure: Functional performance assessment, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: Bezmialem Vakif University, status: RECRUITING, city: Istanbul, country: Turkey, contacts name: Deniz Tuncer, PhD, PT, role: CONTACT, contacts name: Fatma Eren, PT, role: CONTACT, contacts name: Fatma Eren, PT, role: SUB_INVESTIGATOR, contacts name: Deniz Tuncer, PhD, PT, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06363123, orgStudyIdInfo id: BFHHZML20240009, briefTitle: Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-29, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2025-04, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-15, sponsorCollaboratorsModule leadSponsor name: Beijing Friendship Hospital, class: OTHER, descriptionModule briefSummary: The aim of this observational study is to comprehensively analyze the metabolites in plasma samples from multi-cancer patients using advanced mass spectrometry detection technology, in conjunction with metabolomics approaches. The goal is to construct a plasma metabolite database for multi-cancer patients. Simultaneously, we will delve into the exploration and validation of a series of metabolic biomarkers for early multi-cancer diagnosis. The objective is to establish a safer, more convenient, and more sensitive early screening method, thereby providing a reliable scientific foundation and critical evidence for improving the early diagnostic process for individuals at high risk of multi-cancer., conditionsModule conditions: Lung Cancer, conditions: Breast Cancer, conditions: Colorectal Cancer, conditions: Thyroid Cancer, conditions: Gastric Cancer, conditions: Cervical Cancer, conditions: Liver Cancer, conditions: Pancreatic Cancer, conditions: Cholangiocarcinoma, conditions: Prostate Cancer, conditions: Esophageal Cancer, conditions: Ovarian Cancer, conditions: Renal Cell Carcinoma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 2700, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Plasma metabolite content, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Cancer Hospital Chinese Academy of Medical Sciences, status: RECRUITING, city: Beijing, state: Beijing, zip: 100021, country: China, contacts name: Yibin Xie, Ph.D., role: CONTACT, geoPoint lat: 39.9075, lon: 116.39723, locations facility: Beijing Friendship Hospital, Capital Medical University, status: RECRUITING, city: Beijing, state: Beijing, zip: 100050, country: China, contacts name: Li Min, Ph. D., role: CONTACT, phone: +86 13552652141, email: minli@ccmu.edu.cn, contacts name: Bilian Kang, Ph.D., role: CONTACT, phone: +86 18001218793, email: kbl@mail.ccmu.edu.cn, geoPoint lat: 39.9075, lon: 116.39723, locations facility: Hebei Tumor Hospital, status: RECRUITING, city: Shijiazhuang, state: Hebei, zip: 050010, country: China, contacts name: Lianmei Zhao, Ph.D., role: CONTACT, geoPoint lat: 38.04139, lon: 114.47861, locations facility: Zhejiang Cancer Hospital, status: RECRUITING, city: Hangzhou, state: Zhejiang, zip: 310022, country: China, contacts name: Qian Song, Ph.D., role: CONTACT, geoPoint lat: 30.29365, lon: 120.16142, hasResults: False
protocolSection identificationModule nctId: NCT06363084, orgStudyIdInfo id: IST-Nim-PC-6, briefTitle: A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer, statusModule overallStatus: COMPLETED, startDateStruct date: 2016-05-01, primaryCompletionDateStruct date: 2022-07-31, completionDateStruct date: 2023-06-30, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Ruijin Hospital, class: OTHER, descriptionModule briefSummary: This trial is a retrospective, observational study, patients who underwent surgical resection of the pancreas for non-metastatic pancreatic cancer between 2016 and 2022 were selected and divided into two groups according to with (study arm) or without (control arm) nimotuzumab. The primary efficacy endpoint was overall survival (OS)., conditionsModule conditions: Resectable Pancreatic Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: RETROSPECTIVE, enrollmentInfo count: 64, type: ACTUAL, armsInterventionsModule interventions name: Nimotuzumab, outcomesModule primaryOutcomes measure: overall survival (OS）, secondaryOutcomes measure: disease-free survival (DFS), secondaryOutcomes measure: locoregional recurrence-free survival (LRRFS), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06363071, orgStudyIdInfo id: 202000495A3, briefTitle: APA and PAS Training for Gait Initiation in Parkinson's Disease, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-06-13, primaryCompletionDateStruct date: 2025-03-31, completionDateStruct date: 2025-05-31, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Chang Gung University, class: OTHER, descriptionModule briefSummary: Our research focused on understanding the interplay between brain excitability and balance function in patients with Parkinson's disease (PD), alongside evaluating effective physical therapy methods. It highlights the prevalence of non-motor disorders and cognitive impairments among PD patients, including balance and postural issues, cognitive function decline, and gait instability. Additionally, it notes that PD patients exhibit abnormal electrophysiological responses, indicating altered central excitability., conditionsModule conditions: Parkinson Disease, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Weight shift training and APA feedback, interventions name: Paired associative stimulation, outcomesModule primaryOutcomes measure: Balance Performance, primaryOutcomes measure: COP Path Length in Balance Tasks, primaryOutcomes measure: COP Displacement in Balance Tasks, primaryOutcomes measure: Motor Evoked Potentials (MEPs), primaryOutcomes measure: Intracortical Facilitation (ICF), primaryOutcomes measure: Intracortical Inhibition (ICI), primaryOutcomes measure: Walking Speed, primaryOutcomes measure: Step Length, primaryOutcomes measure: Step Time, secondaryOutcomes measure: COP Velocity in Balance Tasks, secondaryOutcomes measure: COP Area in Balance Tasks, secondaryOutcomes measure: Double Support Time, secondaryOutcomes measure: Single Support Time, secondaryOutcomes measure: Swing Time, secondaryOutcomes measure: Stance Time, secondaryOutcomes measure: Cadence, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Chang Gung University, status: RECRUITING, city: Taoyuan, zip: 333, country: Taiwan, contacts name: Ya-Ju Chang, PhD, role: CONTACT, phone: 88632118800, phoneExt: 5515, email: yjchang@mail.cgu.edu.tw, geoPoint lat: 24.95233, lon: 121.20193, hasResults: False
protocolSection identificationModule nctId: NCT06363045, orgStudyIdInfo id: NIDEK-TONOREF-UK-0001, briefTitle: Comparative Study of the NIDEK TONOREF III With Predicate Devices, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-11, completionDateStruct date: 2024-11, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Nidek Co. LTD., class: INDUSTRY, descriptionModule briefSummary: The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device. The secondary objective is to demonstrate that the test device is as safe as the predicate devices., conditionsModule conditions: Intraocular Pressure, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 220, type: ESTIMATED, armsInterventionsModule interventions name: NIDEK TONOREF III, interventions name: Haag-Streit, PERKINS HAND-HELD APPLANATION TONOMETER, interventions name: NIDEK CEM-530, outcomesModule primaryOutcomes measure: Equivalent to legally-marketed devices, primaryOutcomes measure: Equivalent to the pachymeter function, secondaryOutcomes measure: The numbers of adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Aston University, city: Birmingham, zip: B4 7ET, UK, country: United Kingdom, geoPoint lat: 52.48142, lon: -1.89983, hasResults: False
protocolSection identificationModule nctId: NCT06363032, orgStudyIdInfo id: 202110104RINB, briefTitle: Elastography in Predicting Renal Outcome, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-12-27, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: National Taiwan University Hospital, class: OTHER, descriptionModule briefSummary: There are two types of elastography: strain elastography assesses the degree of strain when applying a given amount of force to the skin. Shear-wave elastography assesses the velocity of shear wave propagation within the target lesion. A part of the tissue is deformed by a "push pulse", the velocity of the shear waves propagating within the tissue is detected, and the stiffness of the tissue is assessed based on the detected shear velocity. Shear-wave elastography has been intensively studied in thyroid, breast, liver, cervical lymph nodes, and musculoskeletal diseases with promising result.Transthoracic shear-wave ultrasound is also used for the prediction of lung malignancy.In progressive renal disease, renal function decline correlates with the extent of interstitial fibrosis, irrespective of the original pathology. Experience and research in using shear-wave elastography to study the stiffness of renal parenchyma and renal fibrosis are scanty. The investigators will conduct a prospective observational study. This study aims to provide the information of tissue elasticity in different etiologies of renal diseases and to validate the predictive value of shear-wave elastography in predicting renal function and renal fibrosis.By assuming a power of 0.8, a two-side p value of 0.05, a ratio of 0.2 (sample sizes in negative/positive groups) to detect the difference between area under ROC curve and null hypothesis value (0.8 and 0.7), a target sample of 273 (with a 5% cushion, 260\~290) patients is required., conditionsModule conditions: Kidney Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 500, type: ESTIMATED, armsInterventionsModule interventions name: elastography, outcomesModule primaryOutcomes measure: collect medical record of blood urea nitrogen and Creatinine, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: National Taiwan University Hospital, status: RECRUITING, city: Taipei, country: Taiwan, contacts name: Fan-Chi Chang, role: CONTACT, phone: 886-0223123456, email: leiny.fc@gmail.com, geoPoint lat: 25.04776, lon: 121.53185, hasResults: False
protocolSection identificationModule nctId: NCT06363006, orgStudyIdInfo id: K23C3280, briefTitle: Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2026-01-01, completionDateStruct date: 2027-01-01, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: Peking Union Medical College Hospital, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to evaluate the efficacy and safety of cardonilizumab injection combined with TKI in second-line treatment of advanced hepatocellular carcinoma. The main questions it aims to answer are:* Objective response rate (ORR) for evaluation* Disease Control Rate (DCR); Duration of relief (DoR); Progression free survival (PFS); Total survival time (OS); Safety。, conditionsModule conditions: Hepatocellular Carcinoma, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: TKI+Cardunilimab, outcomesModule primaryOutcomes measure: ORR Full single-arm, open, multicenter prospective clinical study, primaryOutcomes measure: Progression-free Survival (PFS), secondaryOutcomes measure: Disease Control Rate (DCR), secondaryOutcomes measure: Overall Survival (OS), secondaryOutcomes measure: Duration of Response (DOR), secondaryOutcomes measure: Stable Disease (SD), secondaryOutcomes measure: Progression free survival rate, otherOutcomes measure: Any adverse events related with treatment with TKI plus Cardonizumab., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), status: RECRUITING, city: Beijing, state: Beijing, zip: 100730, country: China, contacts name: Haitao Zhao, Professor, role: CONTACT, phone: +861069156042, email: zhaoht@pumch.cn, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False